Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy ; volume:66 ; number:12 ; day:29 ; month:9 ; year:2023 ; pages:2307-2319 ; date:12.2023
Diabetologia ; 66, Heft 12 (29.9.2023), 2307-2319, 12.2023
- Urheber
-
Taskinen, Marja-Riitta
Matikainen, Niina
Björnson, Elias
Söderlund, Sanni
Inkeri, Jussi
Hakkarainen, Antti
Parviainen, Helka
Sihlbom, Carina
Thorsell, Annika
Andersson, Linda
Adiels, Martin
Packard, Chris J.
Borén, Jan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-06008-0
- URN
-
urn:nbn:de:101:1-2024012309084303534824
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Taskinen, Marja-Riitta
- Matikainen, Niina
- Björnson, Elias
- Söderlund, Sanni
- Inkeri, Jussi
- Hakkarainen, Antti
- Parviainen, Helka
- Sihlbom, Carina
- Thorsell, Annika
- Andersson, Linda
- Adiels, Martin
- Packard, Chris J.
- Borén, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins
Blood Lipoproteins Shape the Phenotype and Lipid Content of Early Atherosclerotic Lesion Macrophages: A Dual-Structured Mathematical Model
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins
Blood Lipoproteins Shape the Phenotype and Lipid Content of Early Atherosclerotic Lesion Macrophages: A Dual-Structured Mathematical Model
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins